Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Oilminerdeluxeon Aug 21, 2023 2:56pm
162 Views
Post# 35598393

RE:We are totally blowing Keytruda out of the water

RE:We are totally blowing Keytruda out of the water

Eoganacht wrote: If we get a 450 day 41% durable complete response this will equal Keytruda's 41% CR at any time!

And more than double their 19% 12 month durable CR. 

Keytruda patients could end up being treated up to 34 times! (every 3 weeks for up to 24 months)

And, according to their own website, and depending on what other treatments accompany Keytruda, patients may have to endure:
 
- tiredness or weakness
- nausea
- constipation
- diarrhea
- decreased appetite
- rash
- vomiting
- cough
- trouble breathing
- fever
- hair loss
- inflammation of the nerves that may cause pain
- paralysis in the arms and legs
- low red blood cell count
- low white blood cell count
- decreased platelet count
- high blood pressure
- urinary tract infection
- rash
- low levels of thyroid hormone
- liver problems
- swelling of the lining of the mouth, nose, eyes, throat, intestines, or vagina
- mouth sores
- headache
- weight loss
- stomach-area (abdominal) pain
- joint and muscle pain
- trouble sleeping.

They also advise that this is an incomplete list of possible side effects!


That list is what I like to call: the usual Monday at work....


 

<< Previous
Bullboard Posts
Next >>